Found 71 matching trials
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
PHASE2To assess the efficacy and safety of Human coronavirus immune plasma (HCIP)...
Location
University of Alabama at Birmingham
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels
N/AThis study aims to investigate the pathophysiology of recurrent pericarditi...
Location
Saarland University
COVID Protection After Transplant-Immunosuppression Reduction
PHASE2This study will enroll individuals who have:
* Completed primary series of...
Location
University of California, San Diego
Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals
PHASE2This study is a 4-arm, multicenter, randomized, partly double- blind, contr...
Location
Abteilung Infektiologie Klinik für Innere Medizin II Department Innere Medizin Universitätsklinikum Freiburg
Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations
N/ATo investigate the incidence of SARS-CoV-2 infections after vaccination, to...
Status
Active Not Recruiting
Location
Karolinska University Hospital
SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19)
N/AAssessment of the seroprevalence and sero-incidence of Severe Acute Respira...
Convalescent Plasma vs. Standard Plasma for COVID-19
PHASE1The purpose of this study is to find out if transfusion of blood plasma con...
Location
Stony Brook University Hospital
Biomarkers of Trained Immunity Following MMR Vaccination
N/AThis is a substudy of NCT04333732. The goal of this sub-study is to identif...
Location
Washington University School of Medicine
COVID-19 Protection After Transplant Pilot Study
PHASE2Antibodies are an important part of the body's defense against infection. I...
Location
Johns Hopkins Hospital
Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers
N/AThe main objectives of this study are
1. to establish the prevalence of SA...
Location
Greifswald University Medicine